Alternative Cost-Saving Strategies for Innovative Treatments: Will Medicaid Enter the Value-Based Pricing Market? by Lara Frick September 23, 2020Magellan Health, Magellan RX, Magellan Rx Management, Medicaid, Novel Medications, Outcome Based Pricing, Specialty Pharmacy Trend Alert, Trend Alert, Value Based Purchasing
2019 FDA Approvals: A Year in Review by Lara Frick March 19, 2020Biosimilairs, FDA, FDA Approvals, Magellan Health, Magellan RX, Magellan Rx Management, New Drugs, Novel drugs, Orphan Drugs, Trend Alert
“Drug Shortages: Root Causes and Potential Solutions” – Insight from a FDA Task Force by Lara Frick December 4, 2019Drug Shortages, FDA Drug Shortages, FDA Task Force, Magellan Health, Magellan RX, MEDS Act, MRx, MRx Trend Alert, Trend Alert
21st Century Measles Outbreak by Maryam Tabatabai July 25, 2019CDC, Immunization, Magellan Pharmacy, Magellan Pharmacy Benefits, Measles, Measles Virus, Trend Alert, Vaccination
Going Beyond Traditional Benefits: Healthcare Systems Begin to Address Social Determinants of Health by Rebecca Borgert July 22, 2019Accountable Care Organizations, CMS, Magellan, Magellan Health, Magellan RX, Medicaid, Medicare, Medicare Advantage, SDOH, Trend Alert, Trend Alerts
